Literature DB >> 7295002

Application of free autogenous fibular graft in the treatment of aggressive bone tumours of the distal end of the radius.

P Salenius, S Santavirta, O Kiviluoto, E V Koskinen.   

Abstract

Long-term results of the application of free autogenous fibular graft in the treatment of aggressive bone tumours of the distal end of the radius are presented. Six patients underwent radical resection of the tumour including the articular surface of the distal radius during the period 1969 to 1978, the average follow-up time being 5 years. In one case the tumour was low grade chondrosarcoma, in three cases a giant cell tumour grade two to three and in the remaining two a hemangioma. Five to twelve cm of the distal radius was resected and the defect was replaced using the ipsilateral proximal part of the fibula as free graft. Osteosynthesis was performed end to end with a plate fixation, or side to side with screw fixation. At follow-up, the range of motion in the radiocarpal joint was normal or close to normal in each case and all patients had returned to work within 6 months of the operation. None of the patients presented a recidive of the tumour.

Entities:  

Mesh:

Year:  1981        PMID: 7295002     DOI: 10.1007/bf00378882

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  9 in total

1.  Vascular pedicle fibular transplantation as treatment for bone tumor.

Authors:  S Watari; Y Ikuta; N Adachi; M Murase; K Tsuge
Journal:  Clin Orthop Relat Res       Date:  1978-06       Impact factor: 4.176

2.  Homotransplantation of a half or whole joint.

Authors:  C J Campbell
Journal:  Clin Orthop Relat Res       Date:  1972-09       Impact factor: 4.176

3.  Allograft replacement of all or part of the end of a long bone following excision of a tumor.

Authors:  F F Parrish
Journal:  J Bone Joint Surg Am       Date:  1973-01       Impact factor: 5.284

4.  Homologous joint-transplantation in man.

Authors:  U Nilsonne
Journal:  Acta Orthop Scand       Date:  1969

5.  Massive resection and allograft transplantation in the treatment of malignant bone tumors.

Authors:  H J Mankin; F S Fogelson; A Z Thrasher; F Jaffer
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

6.  Application of the free vascularized bone graft in the treatment of malignant or aggressive bone tumors.

Authors:  A J Weiland; R K Daniel; L H Riley
Journal:  Johns Hopkins Med J       Date:  1977-03

7.  [The place of radiation therapy in the treatment of giant cell tumors of bone (osteoclastomas): results from 32 cases (author's transl)].

Authors:  C Glanzmann; W Horst
Journal:  Strahlentherapie       Date:  1978-02

8.  Free vascularized bone grafts in surgery of the upper extremity.

Authors:  A J Weiland; H E Kleinert; J E Kutz; R K Daniel
Journal:  J Hand Surg Am       Date:  1979-03       Impact factor: 2.230

9.  Wide resection of primary tumors of bone and replacement with massive bone grafts: an improved technique for transplanting allogeneic bone grafts.

Authors:  E V Koskinen
Journal:  Clin Orthop Relat Res       Date:  1978 Jul-Aug       Impact factor: 4.176

  9 in total
  3 in total

1.  Wide excision and ulno-carpal arthrodesis for primary aggressive and recurrent giant cell tumours.

Authors:  S Bhagat; M Bansal; R Jandhyala; H Sharma; P Amin; J P Pandit
Journal:  Int Orthop       Date:  2007-07-21       Impact factor: 3.075

Review 2.  En bloc excision and autogenous fibular reconstruction for aggressive giant cell tumor of distal radius: a report of 12 cases and review of literature.

Authors:  Raghav Saini; Kamal Bali; Vikas Bachhal; Aditya K Mootha; Mandeep S Dhillon; Shivinder S Gill
Journal:  J Orthop Surg Res       Date:  2011-03-08       Impact factor: 2.359

3.  Retrospective Analysis of Giant Cell Tumor Lower End Radius Treated with En bloc Excision and Translocation of Ulna.

Authors:  Amit Vyas; Purnima Patni; Narender Saini; Rahul Sharma; Vinit Arora; S P Gupta
Journal:  Indian J Orthop       Date:  2018 Jan-Feb       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.